Found 607 results
The WSIPP Board of Directors and the 2019 Washington State Legislature directed WSIPP to update previous findings on early childhood education. In 2013, the legislature directed WSIPP to conduct an outcome evaluation and return on investment analysis of the state’s Early Childhood Education and Assistance Program (ECEAP). As part of that assignment, WSIPP produced a report summarizing the national research literature on the long-term effectiveness of early childhood education programs and conducting a benefit-cost analysis for these programs. This report updates those previous findings and presents new findings for three types of programs: 1) state early childhood education programs targeting low-income children, 2) universal state early childhood education programs, and 3) Head Start. We find that increases in academic achievement for participants in these programs are likely to produce long-term monetary benefits that outweigh the costs.
The 2018 Washington State Legislature directed WSIPP to conduct a statewide study on the needs of girls and young women involved in both the juvenile justice and child welfare systems, referred to in the legislation as “dually involved females.” This study compared dually involved females to dually involved males and to females with only juvenile justice involvement in criminal justice system involvement, mental health and substance abuse diagnoses and treatment, medical care, employment, homelessness, teen birth, and use of Temporary Assistance to Needy Families and the Supplemental Nutritional Assistance Program. The study includes a survey of other states regarding systems to address and treat the needs of dually involved youth.
The 2018 Washington State Legislature directed WSIPP to conduct additional cannabis research, supplemental to the ongoing benefit-cost evaluation of cannabis legalization authorized by Initiative 502 in 2012. As part of the new assignments, WSIPP was directed to examine effective methods for suppressing unlicensed cultivation and distribution of marijuana in jurisdictions with legal markets. We found very little evidence on that topic. Instead, we identified numerous factors that could contribute to the survival of the illicit marijuana market in the context of legalization, such as continuing prohibitions in other states and regulations that reduce the competitive advantage of the legal market. We examined key regulatory features in the nine states with licensed non-medical cannabis supply systems and found that states varied widely in the level of restriction imposed on legal supply systems. We conclude by outlining a practical strategy for monitoring illicit market reductions as the state’s approach to legalization develops.
The 2018 Washington State Legislature directed the Washington State Institute for Public Policy (WSIPP) to conduct evidence reviews on step therapy and step therapy exceptions and to summarize step therapy exceptions codified in other states. One goal of the assignment is to determine whether this type of prescription drug utilization management practice has an effect on health outcomes. In this report, we describe the results of our evidence reviews on step therapy and step therapy exceptions and describe the limitations of the research evidence. We also summarize the step therapy exceptions codified in other states and describe Washington’s codified step therapy exception.
In 2018, WSIPP’s Board of Directors approved a contract with the Washington State Juvenile Rehabilitation Administration in conjunction with the Community Juvenile Accountability Act Oversight Committee to evaluate a juvenile court evidence-based program. The contract required WSIPP to evaluate the effectiveness of the Washington State Aggression Replacement Training (WSART) program at reducing recidivism for court-involved youth. In addition to evaluating the overall effects, WSIPP was asked to evaluate for whom the program was most effective and under what conditions the program was most effective. This report evaluates the effects of WSART in Washington State juvenile courts from 2005 to 2016. To the extent possible, we evaluated the varying effects of WSART for subpopulations including males and females; White, Black, and Hispanic youth; younger youth and older youth; high-risk youth and moderate-risk youth; and youth assessed using the BOT and youth assessed using the PACT. Finally, we evaluated differences in the effects of WSART by characteristics of WSART program participation including trainer competence and program completion.
The 2018 Washington State Legislature directed WSIPP to conduct additional cannabis research, supplemental to the ongoing benefit-cost evaluation of cannabis legalization authorized by Initiative 502 in 2012. As part of this supplemental work, WSIPP was directed to examine current data collection methods measuring the use of marijuana by youth and potential ways to improve on these methods. In this report, we focused on the Washington Healthy Youth Survey, the primary source of data on cannabis use among Washington youth. We reviewed the evidence for harmful consequences of cannabis use focusing on how cannabis use was measured, and we examined recently developed surveys that reflect the state-of-the-art in survey measurement of marijuana use. With this information, we identified a set of potential improvements to the HYS while considering the practical limitations of revisions to an existing survey.
The 2018 Washington State Legislature directed WSIPP to conduct a study of single-payer and universal health coverage systems. Our interim report discussed policies to promote universal health care, outlined health care coverage and expenditures in Washington, examined potential effects of implementing single-payer health care, discussed challenges to implementing it, and summarized characteristics of national and state single-payer proposals. Our final report examines universal coverage and single-payer systems in other high-income countries, which have achieved universal coverage and substantially lower health care spending than the US. These other countries, both single- and multi-payer, have mechanisms to control the prices of medical services and pharmaceuticals. They have lower insurer administrative costs and, in the case of single-payer countries, lower provider administrative burdens. These countries also have, to varying degrees, limited the utilization of some high-margin procedures and advanced imaging and discouraged the diffusion of medical technologies and drugs that have modest or uncertain effectiveness. Individuals in these countries have fewer financial barriers to health care and more equitable access to care across income groups than in the US. Finally, the higher US health expenditures do not translate to better health outcomes and quality of care for the entire population.
Previous reports published by the Washington State Institute for Public Policy have shown a gradual decline in recidivism for adults released from prison through the 1990s and early 2000s. This report updates WSIPP’s 2011 review of recidivism trends for adults released from prison and expands the scope of our report to include youth populations and additional adult populations. Our analyses found gradual declines in overall recidivism for all four populations from FY 1995–FY 2014. However, examination of recidivism trends by type of recidivism, type of initial offense, and demographic characteristics indicate that changes in trends varied across sub-populations.
The 2018 Washington State Legislature directed WSIPP to examine higher education funding models in states comparable to Washington. To fulfill this assignment, we interviewed key stakeholders from 11 states with similar higher education systems including Colorado, Georgia, Illinois, Kansas, Minnesota, Ohio, Oregon, Tennessee, Texas, Virginia, and Wisconsin. In this report, we discuss the differences in budget-setting, tuition-setting, and salary-setting authorities by state. We describe the funding methods used for higher education appropriations and allocations in each state. Finally, we determine the proportions of overall higher education funding and higher education salary and benefit increases that come from each state’s general fund (or equivalent accounts).
Adam Darnell, Rebecca Goodvin, Sara del Moral, Casey Hicks, Paige Wanner, Eva Westley - December 2018
Initiative 502 (I-502) legalized recreational cannabis for adults in Washington State. The law directs a portion of cannabis revenues to be spent on substance abuse prevention and treatment services that have been demonstrated to be effective. Specifically, state law requires at least 85% of programs funded by cannabis revenues to be evidence-based or research-based and up to 15% to be promising practices. In this inventory, we rate the research evidence for programs intended for the prevention or treatment of youth substance use, and we identify those specifically effective for marijuana. The 2018 Washington State Legislature directed WSIPP to update this inventory. This is the third update in the series.